Waldenstrom’s macroglobulinaemia (WM)
What is Waldenstrom’s macroglobulinaemia?
Waldenstrom’s macroglobulinaemia (WM) is an uncommon type of blood cancer. WM (lymphoplasmacytic lymphoma) is a disorder that has features in common with indolent non-Hodgkin lymphoma and with myeloma. WM more closely resembles indolent lymphoma in its progression as a disease.
In WM, abnormal lymphoma and plasma cells produce excess amounts of a particular antibody (or immunoglobulin) called IgM. The “M” in IgM stands for macroglobulin and is where the naming macroglobinaemia is derived from. Over time IgM builds up in the bone marrow, spleen and blood, causing it to become thicker and blood flow to various body organs may be impaired. This complication occurs in approximately 10-30% of people with this disease. Symptoms may include changes in vision, headaches, hearing loss, abnormal bleeding and confusion. People can also experience lethargy and fatigue, and are at increased risk of infection.
Because WM affects the plasma cells it is sometimes confused with myeloma, though it does not cause the bone damage seen in myeloma patients and is usually treated in a different way. Most patients are diagnosed with WM after they are affected by the symptoms resulting from the build-up of the antibody in their blood.
Waldenstrom’s macroglobulinaemia: the basics
How common is Waldenstrom’s macroglobulinaemia?
Who gets Waldenstrom’s macroglobulinaemia?
What causes Waldenstrom’s macroglobulinaemia?
What are the symptoms of Waldenstrom’s macroglobulinaemia?
More information about Waldenstrom’s Macroglobulinaemia
WM diagnosis WM treatment Side-effects of WM treatmentLast updated on May 20th, 2024
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.